rs1553353452
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_005633.4(SOS1):c.2671G>A(p.Glu891Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005633.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- fibromatosis, gingival, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary gingival fibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005633.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOS1 | NM_005633.4 | MANE Select | c.2671G>A | p.Glu891Lys | missense splice_region | Exon 16 of 23 | NP_005624.2 | ||
| SOS1 | NM_001382394.1 | c.2650G>A | p.Glu884Lys | missense splice_region | Exon 16 of 23 | NP_001369323.1 | |||
| SOS1 | NM_001382395.1 | c.2671G>A | p.Glu891Lys | missense splice_region | Exon 16 of 22 | NP_001369324.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOS1 | ENST00000402219.8 | TSL:1 MANE Select | c.2671G>A | p.Glu891Lys | missense splice_region | Exon 16 of 23 | ENSP00000384675.2 | ||
| SOS1 | ENST00000395038.6 | TSL:5 | c.2671G>A | p.Glu891Lys | missense splice_region | Exon 16 of 22 | ENSP00000378479.2 | ||
| SOS1 | ENST00000692089.1 | c.2560G>A | p.Glu854Lys | missense splice_region | Exon 15 of 22 | ENSP00000508626.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Noonan syndrome 4 Pathogenic:1Uncertain:1
Based on the classification scheme VCGS_Germline_v0.6.1, this variant is classified as 3A-VUS. Following criteria are met: 0101 - Gain of function is a known mechanism of disease for this gene. 0107 - This gene is known to be associated with autosomal dominant disease. 0200 - Variant is predicted to result in a missense amino acid change from glutamic acid to lysine (exon 16). It is also a non-canonical splice region variant without proven consequence on splicing (no functional evidence available). 0301 - Variant is absent from gnomAD. 0502 - Missense variant with conflicting in silico predictions and high conservation. Abnormal splicing is not predicted by in silico tools. 0600 - Variant is located in an annotated domain or motif that does not have a well established function (RasGEF domain; PDB, NCBI). 0705 - No comparable variants in relevant codon/region have previous evidence for pathogenicity. 0802 - Moderate previous evidence of pathogenicity in unrelated individuals. It has been previously reported likely pathogenic in a patient with Noonan syndrome (ClinVar). 0905 - No published segregation evidence has been identified for this variant. 1007 - No published functional evidence has been identified for this variant. 1205 - Variant is maternally inherited.
Noonan syndrome Pathogenic:1
The p.Glu891Lys variant in SOS1 has been identified by our laboratory as a de no vo variant in one individual with clinical features of Noonan syndrome. This var iant was absent from large population studies. Computational prediction tools an d conservation analysis do not provide strong support for or against an impact t o the protein. In summary, although additional studies are required to fully est ablish its clinical significance, the p.Glu891Lys variant is likely pathogenic.
RASopathy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 891 of the SOS1 protein (p.Glu891Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SOS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 505408).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at